从治疗到预防:多西环林在预防性传播感染方面的潜力
James Bird1, Basil Alawyia1, Nikolaos Spernovasilis2
1Department of Basic and Clinical Sciences, University of Nicosia, Nicosia 2417, Cyprus.
Antibiotics (Basel, Switzerland)
|January 8, 2025
概括
在高危人群中,多西环素暴露后预防 (DoxyPEP) 在预防高危人群中的克拉米迪亚和梅毒方面表现有前途,但其对淋病的有效性有限. 仔细考虑抗微生物药物耐药性和公平获取对其实施至关重要.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 全球性传播感染 (STIs) 发生率上升,特别是在与男性发生性关系的男性 (MSM) 和跨性别女性 (TGW) 中.
- 多西环素暴露后预防 (DoxyPEP) 已成为潜在的预防性感染的预防措施.
研究的目的:
- 评估DoxyPEP在预防性传播感染方面的有效性和挑战.
- 探索DoxyPEP实施对公共卫生和抗菌素耐药性的影响.
主要方法:
- 对DoxyPEP疗效的临床试验和指导方针的审查.
- 分析潜在的挑战,包括抗菌素耐药性,公平获取和行为影响.
主要成果:
- 在美国和法国的试验中,DoxyPEP在减少MSM和TGW的克拉米迪亚和梅毒发病率方面表现出有效性.
- 观察到对淋病的有效性有限,而DoxyPEP在肯尼亚的 cisgender妇女中无效.
- 常见的STI病原体和其他细菌的抗菌素耐药性是一个重大问题.
结论:
- 在特定的高风险人群中,DoxyPEP是预防性病的有希望的工具,但需要仔细实施.
- 解决抗微生物药物耐药性,确保公平获取和监测公共卫生影响至关重要.
- 未来的研究应该调查DoxyPEP与疫苗等其他预防策略的整合.
相关概念视频
Sexually Transmitted Infections
269
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
269
Transmission-based Precautions I: Contact, Enteric, and Droplets
3.4K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
3.4K
Infection
7.6K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.6K
Transmission-based Precautions II: Airborne and Protective Environment
1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Surface Membrane Barriers
1.0K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.0K


